Related Experiment Video
Updated: Mar 16, 2026

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Helicobacter pylori and extragastric diseases
Elisabetta Goni1, Francesco Franceschi2
1Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Helicobacter pylori infection is linked to extragastric diseases beyond the stomach. Recent studies explore its association with cardiovascular, neurologic, and metabolic conditions, expanding our understanding of its systemic effects.
Area of Science:
- Gastroenterology and Infectious Diseases
- Microbiology
- Systemic Manifestations of Infection
Background:
- Helicobacter pylori is a bacterium primarily known for causing gastric diseases.
- Emerging evidence suggests H. pylori infection may contribute to a wide range of extragastric conditions.
- The mechanisms by which H. pylori influences distant biologic processes are under investigation.
Purpose of the Study:
- To review and summarize recent research on extragastric diseases associated with H. pylori infection.
- To highlight the growing body of evidence linking H. pylori to various systemic conditions.
- To provide an overview of the most relevant studies published in the past year.
Main Methods:
- Literature review of studies published within the last year.
- Focus on research investigating H. pylori's association with extragastric manifestations.
- Synthesis of findings from studies on cardiovascular, neurologic, hematologic, dermatologic, and metabolic diseases.
Main Results:
- Established roles of H. pylori in idiopathic thrombocytopenic purpura, sideropenic anemia, and vitamin B12 deficiency.
- Growing evidence supports H. pylori's association with cardiovascular diseases.
- Promising results indicate links between H. pylori and neurologic, dermatologic, diabetes mellitus, and metabolic syndrome.
Conclusions:
- H. pylori infection extends its influence beyond the gastrointestinal tract, affecting multiple organ systems.
- Further research is warranted to elucidate the pathogenic mechanisms underlying these extragastric associations.
- The findings underscore the systemic impact of H. pylori and its potential role in diverse pathologies.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

